Medtronic has received FDA 510(k) clearance for the Kyphon Xpander II inflatable bone tamp for treating vertebral compression fractures with the minimally invasive Kyphon balloon kyphoplasty, according to a company news release.
The device was designed to improve pre-determined inflation patterns and exert greater lifting force than the first generation of the device. The Kyphon Xpander II allows the physician to maintain inflation of one IBT while delivering polymethylmethacrylate bone cement on the contralateral side of the vertebrae.
The product is available in the U.S. market and is expected to be available internationally in 2011.
Read the release on Medtronic's Kyphon Xpander II.
Read other coverage on Medtronic:
- Medtronic, Others Join to Promote Vertebral Compression Fracture Awareness
- Medtronic Launches KYPHON Express Curette
- Medtronic Exclusively Distributes Tissuemed's Obex NeuroFilm
The device was designed to improve pre-determined inflation patterns and exert greater lifting force than the first generation of the device. The Kyphon Xpander II allows the physician to maintain inflation of one IBT while delivering polymethylmethacrylate bone cement on the contralateral side of the vertebrae.
The product is available in the U.S. market and is expected to be available internationally in 2011.
Read the release on Medtronic's Kyphon Xpander II.
Read other coverage on Medtronic:
- Medtronic, Others Join to Promote Vertebral Compression Fracture Awareness
- Medtronic Launches KYPHON Express Curette
- Medtronic Exclusively Distributes Tissuemed's Obex NeuroFilm